Dr. Merril Garnett
Dr. Merrill Garnett is the founder and CEO of Garnett McKeen Laboratory, Inc. Holding a D.D.S. from New York University, and graduate study in chemistry and biochemistry, Dr. Garnett has had research laboratories at the Central Islip State Hospital, Waldemar Medical Research Foundation, Northport Veterans’ Administration Medical Center, and the High Technology Incubator of The State University of New York at Stony Brook.Dr. Garnett’s principle laboratory discoveries reveal the presence of corollary
dynamics of the genetic code by which specific DNA coded segments and
cell membranes exchange ultra-low frequency sinusoidal electrical currents.
According to his theory, these pulsed currents are the basis of all
physiological pulses and determine the polarization, charge and folding of
enzymes, nucleic acids and membrane phospholipids. The restoration of
these charge transfer pathways form the basis of several new methods of
Investigators at the University of Utah and Columbia University have
collaborated in studies of his compound, DNA Reductase. This is the first
non-toxic chemotherapeutic agent, a liquid crystal complex of palladium and lipoic acid. Other new drugs are also under development. Dr. Garnett has
been issued three United States patents related to the treatment of tumors and psoriasis.
The above Bio. & Research information can be found at www.electrogenetics.com
Article Written by Dr. Merril Garnett
The Inductive Phase State of Gene Polymer Pulsation Compensates for the
Absence of Time, Energy, and Distance Parameters of the Genetic Code
The modern genetic code is a gene base sequence theory whose regulatory
influence is implied from the feedback experiments of bacterial genetics and
modern mammalian genetics. Nevertheless, this intellectual framework has
failed to disclose the mechanisms of differentiation intrinsic to understanding
cell development, aging, and cancer. The weakness lies in the absence of
Since 1987 a few investigators have sought and observed other explanations at the DNA level. These
reports describe energy storage and retrieval in the unstacked gene base sequences, and DNA oscillations. From measurements with Raman spectroscopy (Volkov & Kosevich), and from theoretical calculations (Bistolfi, also Prohofsky et al, also Chou et al.) an electron dynamic second DNA code emerges. I have reported that measurements with impedance spectroscopy and frequency domain analysis, confirm the oscillatory data. This concept allows the synthesis of drugs designed to act on the exchange of energy at the DNA level. The drugs act as electro-chemical reagents, demonstrating the catalytic addition of electrons to DNA. In so doing it becomes clear that a variety of protozoa and tumor cell lines suffer membrane disruption from the 250 millivolt inward current.
In other parallel research, since 1988, workers at Columbia and Caltech have made abundant
reports showing stacked sequences of gene bases are able to transfer photo-activated electrons
within DNA in the long axis. This is a strong argument for gene to gene signaling or energy transfer.
It becomes necessary to integrate all these reactions into equivalent electronic circuitry as a cell function.
To this end the impedance plots were examined from the conventions of electro-chemistry. Since DNA
manifests three arcs in the upper right quadrant of the Nyquist plot, it is therefore a variable capacitor
at negative voltages. At positive voltages, when exposed to a corrosion driven cation pump, DNA and
RNA manifest pseudo-inductance. It is this pulsed inductive magnetic component which is capable of long
range penetration of the heterogeneous biological state, and which carries cell to cell integrative
biopotential feedback. Fatty acid and phospholipid electron donors are capacitative. Synthetic
chemotherapy agents which transfer current to DNA and RNA share with the gene polymers a common
ultra-low frequency – demonstrating resonance. These data support models for a cellular circuit directly
analogous to oscillator or tank circuits.
These oscillator or pulsed circuits use a frequency
at .285 Hertz – about 17 beats/minute. It is this
frequency which is believed to be responsible for
the apoptosis effects of POLY-MVA. High flux
oscillating electron flow produces clonal selection
allowing arrival of only the competent electron
transfer cell systems, and therefore presents a
dynamical model for the design of anti-cancer
Two catalytic chemotherapy agents have been
synthesized: the liquid crystal polymer of palladium
and lipoic acid acts as a DNA reductase POLY-MVA,
and its new derivative act as an RNA reductase.
These have different anti-tumor spectra and receptor mechanisms. The RNA reductase produces
dense heterochromatin which is traditionally a gene suppressive action. We are trying to reproduce
DNA to RNA hybridization in vitro to account for the heterochromatic mechanics of gene suppression
by RNA reductase.
In summary, genetic control extends from cell to cell by long range pulsed magnetic induction according
to the Faraday-Maxwell-Heaviside law: curl B = 4 pi C, translated conceptually as – the net circulating
magnetic field around a wire or a long molecule carrying a current is equal to 4 pi times the current